UK Secures 90 Million Doses of COVID-19 Vaccine from Pfizer, BioNTech and Valneva

The UK has secured 90 million doses of COVID-19 vaccines from Pfizer, BioNTech and French drugmaker Valneva.

Pfizer and BioNTech will provide 30 million doses of its mRNA-based COVID-19 vaccine. Valneva will provide 60 million doses of its inactivated vaccine candidate and could provide an additional 40 million doses.

The UK has also secured COVID-19 neutralizing antibodies from AstraZeneca for people who cannot tolerate vaccines.